Skip to content

Clinical trials

Phase 3 Parkinson Disease trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 3 Country / region: Austria Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20061
20074
20081
20091
20143
20153
20182
20194
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
Theravance Biopharma3
Adamas Pharmaceuticals, Inc.2
Sumitomo Pharma America, Inc.2
UCB Pharma2
Acorda Therapeutics1
Biotie Therapies Inc.1
Britannia Pharmaceuticals Ltd.1
Eisai Limited1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease23
Dyskinesias4
Parkinsonian Disorders4
Dizziness3
Hypotension3
Pure Autonomic Failure3
Syncope3
Hypotension, Orthostatic2
Multiple System Atrophy1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.